THIRD ROCK VENTURES V, L.P. sold 6.0% of their position (426K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $17.18M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/21/2026ACC: 0001193125-26-167636
10% Owner
Since Jun 2024
-426K
Net shares
Net seller
$17.18M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
426K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−426K
Price / share
$40.32
Trade value
$17.18M
% of position
6.0%
4/17/2026
7.14M→6.71M
Total
Net shares
−426K
Net value
-$17.18M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2026 | S · Sale | −426K | $40.32 | $17.18M | 6.0% | 7.14M | 6.71M |
| Total | −426K | -$17.18M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned969.22K
Total
969.22K indirect969.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 969.22K | Indirect |
| Total | 969.22K | 969.22K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported